BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Chemi Nutra & Increnovo File Patent For Phosphatidylserine’s (PS) Ability To Maintain Healthy Testosterone Levels & Benefit Healthy Aging In Men


9/25/2009 10:19:57 AM

White Bear Lake, MN – In 2007, Chemi Nutra and Increnovo began a collaboration involving discovery and investigation into PS’s ability to influence cortisol and testosterone levels in exercising and non-exercising men. As a result of these discoveries, the two companies proudly announce the filing of a novel patent (US Patent Application 20090143339) that will have major implications in men’s healthy aging. Specifically, the patent describes the oral use of PS to maintain healthy testosterone levels, targeted to men experiencing age related declines in testosterone, exercise induced declines in testosterone, and / or hypogonadism.

Scott Hagerman, president of Chemi Nutra said, “There has been a lot of research in recent years involving PS in the sports performance realm - looking at cortisol, stress and immune health, muscle soreness reduction and recovery, and improvements in weightlifting, running, and golf. This exciting new discovery will open additional doors for the use of PS in healthy aging, strength training, and body composition management in men. I am confident that PS will move beyond its well known cognitive enhancing health benefits and into this new area of use, as people become aware of these newest hormone related attributes."

“For the first time, it is now proven that short-term supplementation with a moderate dose of PS not only prevents a stress induced increase in cortisol concentrations, PS additionally can naturally benefit impaired testosterone levels”, said Dr. Martin Purpura, Managing Member of Increnovo. “These new findings, protected by this recently published pending patent, will open new markets for PS-based sports nutrition and anti-aging nutritional supplements, and we intend to immediately pursue several very promising applications with selected customers."

Chemi Nutra is the US business unit of parent company Chemi S.p.A., a privately held pharmaceutical and nutraceutical company based in Milan, Italy. Chemi, with cGMP certified manufacturing facilities in Italy and Brazil, is best known in the US nutritional arena for its introduction of phosphatidylserine (PS), the popular dietary supplement which has been granted two qualified health claims by the FDA, and is used to enhance learning, memory, and concentration, exercise performance, and youthful wellbeing, and to reduce stress.

Increnovo, based in Milwaukee, Wisconsin, was founded in 2007, and is an independent consulting company focused on the dietary supplement, food, beverage, and cosmetic industries. Increnovo is dedicated to scientifically proven, patent protected, premium ingredients and finished functional products.


Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES